Published in J Virol on May 02, 2007
Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog (2013) 1.22
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis. Leukemia (2013) 1.16
Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J Virol (2008) 1.07
The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol (2014) 1.05
HBV replication is significantly reduced by IL-6. J Biomed Sci (2009) 1.02
Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China. Int J Clin Exp Pathol (2013) 0.99
Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cell Mol Immunol (2010) 0.94
Management of rheumatic disease with comorbid HBV or HCV infection. Nat Rev Rheumatol (2012) 0.92
Relationship between TNF-<alpha> gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS One (2011) 0.91
Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation. Front Immunol (2014) 0.88
Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment. World J Gastroenterol (2012) 0.88
Hepatitis B virus replication and release are independent of core lysine ubiquitination. J Virol (2009) 0.88
The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. Virus Res (2010) 0.84
Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase. J Virol (2011) 0.83
Hepatitis B: future curative strategies. Curr Opin Infect Dis (2014) 0.81
The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection. Hepat Res Treat (2012) 0.80
Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection. J Virol (2013) 0.79
Circulating cytokines and histological liver damage in chronic hepatitis B infection. Hepat Res Treat (2013) 0.78
Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen. Sci Rep (2016) 0.78
The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde. Clin Transl Immunology (2016) 0.78
Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. J Virol (2014) 0.77
Can engineered "designer" T cells outsmart chronic hepatitis B? Hepat Res Treat (2010) 0.76
Importin β Can Bind Hepatitis B Virus Core Protein and Empty Core-Like Particles and Induce Structural Changes. PLoS Pathog (2016) 0.76
Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population. Hepat Mon (2016) 0.75
The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation. PLoS One (2015) 0.75
Treatment of rheumatic diseases and hepatitis B virus coinfection. Rheumatol Int (2014) 0.75
Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway. PLoS One (2017) 0.75
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat (2004) 13.18
Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J Virol (1984) 8.32
TNF-R1 signaling: a beautiful pathway. Science (2002) 7.98
Viral clearance without destruction of infected cells during acute HBV infection. Science (1999) 6.78
An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol (1993) 3.72
Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A (1994) 3.34
Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry (1996) 3.00
Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science (2001) 2.98
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology (1996) 2.94
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science (2003) 2.84
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol (1992) 2.54
Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol (1997) 2.50
Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol (2000) 2.49
Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol (1994) 2.29
Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol (1992) 2.25
Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity (2002) 2.17
The host type I interferon response to viral and bacterial infections. Cell Res (2005) 2.12
To kill or to cure: options in host defense against viral infection. Curr Opin Immunol (1996) 2.06
Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol (1994) 2.05
Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J Biol Chem (2002) 2.01
Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest (1996) 1.96
Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J Virol (1994) 1.94
Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol (1999) 1.92
Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J Virol (2000) 1.79
Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol (1994) 1.78
Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Virology (1999) 1.76
Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J Virol (1993) 1.76
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol (2000) 1.73
Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med (2000) 1.72
Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J Virol (1994) 1.66
Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J Virol (1995) 1.66
A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J Virol (2002) 1.61
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol (2002) 1.61
Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol (2002) 1.58
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol (2003) 1.55
Nuclear import and export functions in the different isoforms of the AUF1/heterogeneous nuclear ribonucleoprotein protein family. J Biol Chem (2003) 1.54
Observed hysteresis of virus capsid disassembly is implicit in kinetic models of assembly. J Biol Chem (2003) 1.53
A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle. J Cell Biol (1994) 1.51
Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J Virol (2005) 1.47
Cytokine-mediated control of viral infections. Virology (2000) 1.44
TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol (1999) 1.40
In vitro model for the nuclear transport of the hepadnavirus genome. J Virol (1997) 1.38
Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med (2000) 1.35
Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry (2004) 1.28
In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J Gen Virol (1991) 1.22
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol (2001) 1.20
Mitochondrial glutathione: hepatocellular survival-death switch. J Gastroenterol Hepatol (2006) 1.16
La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol (1999) 1.15
Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J Virol (2000) 1.12
Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes. J Virol (1999) 1.12
Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol (1999) 1.11
Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins. J Virol (2003) 1.10
Assembly and antigenicity of hepatitis B virus core particles. Intervirology (1995) 1.10
Alternate exon insertion controls selective ubiquitination and degradation of different AUF1 protein isoforms. Nucleic Acids Res (2002) 1.06
Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology (2001) 1.05
Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet (1990) 1.02
Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids? J Virol (2001) 0.99
Immune responses to duck hepatitis B virus infection. Dev Comp Immunol (2000) 0.97
Phosphorylation of the core protein of hepatitis B virus by a 46-kilodalton serine kinase. J Virol (1998) 0.97
Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J (2006) 0.96
Negative regulation of hepatitis B virus replication by cellular Hsp40/DnaJ proteins through destabilization of viral core and X proteins. J Gen Virol (2006) 0.94
Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50. Biochem J (1996) 0.93
Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12. J Virol (2001) 0.90
Hepatitis B virus cccDNA clearance: killing for curing? Hepatology (2005) 0.86
Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol (1993) 0.84
Comparing capsid assembly of primate lentiviruses and hepatitis B virus using cell-free systems. Virology (2005) 0.84
Translational control in cancer. Nat Rev Cancer (2010) 4.59
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol (2008) 2.61
Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys (2007) 2.55
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell (2007) 2.44
eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. J Cell Biol (2008) 2.26
Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol (2009) 1.99
Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs (2007) 1.95
mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell (2012) 1.86
Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol Cell Biol (2003) 1.79
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol (2006) 1.76
Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev (2006) 1.74
Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J Biol Chem (2004) 1.63
Nutritional control of mRNA stability is mediated by a conserved AU-rich element that binds the cytoplasmic shuttling protein HuR. J Biol Chem (2002) 1.61
Ethical, legal, and social issues related to genomics and cancer research: the impending crisis. J Am Coll Radiol (2005) 1.60
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol (2003) 1.55
Nuclear import and export functions in the different isoforms of the AUF1/heterogeneous nuclear ribonucleoprotein protein family. J Biol Chem (2003) 1.54
Regulation of protein synthesis by ionizing radiation. Mol Cell Biol (2009) 1.52
Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J Virol (2005) 1.47
Ubiquitin-dependent mechanism regulates rapid turnover of AU-rich cytokine mRNAs. Proc Natl Acad Sci U S A (2002) 1.46
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res (2010) 1.43
Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes Dev (2004) 1.30
Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. J Virol (2003) 1.28
Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay. RNA (2006) 1.22
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Res Treat (2010) 1.12
Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. J Invest Dermatol (2008) 1.10
Mitotic raptor promotes mTORC1 activity, G(2)/M cell cycle progression, and internal ribosome entry site-mediated mRNA translation. Mol Cell Biol (2010) 1.09
Intra- and interfractional patient motion for a variety of immobilization devices. Med Phys (2005) 1.09
Alternate exon insertion controls selective ubiquitination and degradation of different AUF1 protein isoforms. Nucleic Acids Res (2002) 1.06
Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein. J Virol (2004) 1.03
Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and -independent SDF-1 induction. Blood (2010) 1.03
The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. Mol Cell Biol (2006) 1.02
Lsm proteins bind and stabilize RNAs containing 5' poly(A) tracts. Nat Struct Mol Biol (2007) 1.02
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc Natl Acad Sci U S A (2012) 1.00
Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs. J Virol (2005) 0.99
Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients. PLoS One (2013) 0.98
Inflammatory breast cancer cells are constitutively adapted to hypoxia. Cell Cycle (2009) 0.98
UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest (2002) 0.98
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97
Members of the NuRD chromatin remodeling complex interact with AUF1 in developing cortical neurons. Cereb Cortex (2008) 0.95
AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol (2010) 0.94
Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells. Mol Cancer Res (2008) 0.92
Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1. J Biol Chem (2008) 0.91
Targeting the mTOR/4E-BP pathway in endometrial cancer. Clin Cancer Res (2011) 0.90
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. J Cell Mol Med (2010) 0.90
Atypical ezrin localization as a marker of locally advanced breast cancer. Breast Cancer Res Treat (2012) 0.89
Cutaneous low-dose radiation increases tissue vascularity through upregulation of angiogenic and vasculogenic pathways. J Vasc Res (2010) 0.88
The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast (2011) 0.87
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. Nucleic Acids Res (2013) 0.87
Childhood abuse and intake severity in alcohol disorder patients. J Trauma Stress (2006) 0.86
Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PLoS One (2013) 0.86
Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model. NMR Biomed (2011) 0.86
Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells. Cancer Res (2013) 0.85
Alcohol relapses associated with September 11, 2001: a case report. Subst Abus (2003) 0.84
Physiological networks and disease functions of RNA-binding protein AUF1. Wiley Interdiscip Rev RNA (2014) 0.84
Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells. Cytokine (2009) 0.83
Randomized trial of a computer-tailored intervention for patients with depression. Am J Health Promot (2011) 0.82
The regulation of protein synthesis in cancer. Prog Mol Biol Transl Sci (2009) 0.81
Endothelin-1 upregulates MCAM in melanocytes. J Invest Dermatol (2004) 0.78
Endothelin-1 in the tumor microenvironment correlates with melanoma invasion. Melanoma Res (2016) 0.77
Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer. Breast Cancer Res Treat (2010) 0.77
Akt and PI3K-dependent but CREB-independent upregulation of MCAM by endothelin-3 in human melanocytes. Melanoma Res (2014) 0.77
Glioma-like proliferation within tissues excised as tubers in patients with tuberous sclerosis complex. Acta Neuropathol (2008) 0.75